Intuitive Surgical Projects $165M Tariff Hit In 2025, Says Wait-And-See On Mitigation

Company Fears Losing Chinese Tender and Signals Strategic Supply Chain Shifts

Despite near-term cost pressures, Intuitive Surgical is expanding manufacturing and R&D in North America and Europe to meet demand for Ion, X and Xi systems.

The da Vinci robotic surgery maker is now forecasting a 1.7 percentage point gross margin headwind from newly implemented and expected trade barriers, primarily driven by escalating US-China tariffs.
Key Takeaways
  • Tariff costs will increase through 2025, driven by Chinese and US import duties.

Intuitive Surgical is bracing for a $165m hit to its 2025 cost of sales as rising global tariffs look set...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Medtech Insight